Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
- 25 January 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 61 (5), 1246-1267
- https://doi.org/10.1007/s10620-016-4040-6
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many developed countries, affecting an estimated 30 % of the adult population. In this updated clinical review, we summarize the current knowledge regarding the strong association between NAFLD and the risk of coronary heart disease (CHD) and other functional, structural, and arrhythmic cardiac complications (e.g., left ventricular dysfunction, heart valve diseases and atrial fibrillation). We also briefly discuss the putative biological mechanisms linking NAFLD with these important extra-hepatic complications. To date, a large body of evidence has suggested that NAFLD is not simply a marker of CHD and other functional, structural, and arrhythmic cardiac complications, but also may play a part in the development and progression of these cardiac complications. The clinical implication of these findings is that patients with NAFLD may benefit from more intensive surveillance and early treatment interventions aimed at decreasing the risk of CHD and other cardiac and arrhythmic complications.Keywords
This publication has 139 references indexed in Scilit:
- Sonographic Evaluation for Predicting the Presence and Severity of Coronary Artery DiseaseUltrasound Quarterly, 2013
- Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate VariabilityPLOS ONE, 2013
- Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromesEuropean Journal of Clinical Investigation, 2013
- Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: The Jackson Heart StudyAtherosclerosis, 2012
- Gut microbiome, obesity, and metabolic dysfunctionJCI Insight, 2011
- Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline DeficiencyGastroenterology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Serum γ-Glutamyl Transferase and Risk of Heart Failure in the CommunityArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009
- Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart DiseaseCirculation, 2007